Related Experiment Videos
[Thymidine phosphorylase and angiogenesis]
1Dept. of Cancer Chemotherapy, Faculty of Medicine, Kagoshima University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 17, 2000
Summary
Thymidine phosphorylase (TP) promotes tumor growth and survival by aiding angiogenesis and preventing cell death. Inhibiting TP with TPI can suppress tumor growth and metastasis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Thymidine phosphorylase (TP), also known as platelet-derived endothelial cell growth factor (PD-ECGF), is a key enzyme.
- TP exhibits angiogenic properties and enhances cellular resistance to hypoxia-induced apoptosis.
- Elevated TP expression correlates with increased microvessel density, tumor invasion, and poorer prognosis in various solid malignancies.
Purpose:
- To investigate the role of Thymidine phosphorylase (TP) in tumor progression.
- To evaluate the therapeutic potential of TP inhibition using TPI.
Summary:
- Thymidine phosphorylase (TP) plays a critical role in tumor angiogenesis and survival.
- TP expression is a significant prognostic marker in several types of cancer.
- TP inhibitor (TPI) effectively suppresses tumor growth and metastasis by targeting TP activity.
Impact:
- Understanding TP's function provides insights into tumor biology.
- TP inhibition represents a potential therapeutic strategy for cancer treatment.
- Targeting TP may offer a novel approach to combatting tumor invasion and metastasis.